By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



38 the Fenway

Boston  Massachusetts  02215  U.S.A.
Phone: 617-536-0220 Fax: 617-536-0657



Company News
Replikins Release: First Response To Zika Replikins Vaccine Candidates Reported 5/6/2016 6:35:21 AM
Zika, Dengue And Japanese-Encephalitis Trivalent Synthetic Replikins Vaccine-Blocker Candidate Being Tested In Animals, With July 2016 Goal To Begin Human Trials 4/13/2016 6:42:12 AM
MERS And Ebola Replikins Synthetic Vaccine-Blocker Candidates Presented At Meeting Of Int'l Society For Neglected Tropical Diseases At Wellcome Trust May 20th 6/5/2015 6:31:06 AM
Replikins Release; New Genomic Analysis Shows H5N1 (Bird Flu) Replikin Count Highest Among Five Influenza Strains 10/10/2013 9:22:43 AM
Replikins Release: Highest Genomic Replikin Counts Found in Antibiotic-Resistant Bacteria 3/14/2013 10:19:51 AM
Replikins Release: Recent Outbreak of Hand-Foot-Mouth Disease in 2.2 Million Children (WHO) Preceded and Predicted by Increase in the HFMD Genomic Replikin® Count 2/20/2013 9:51:24 AM
New Shared Synthetic Replikins Cancer Vaccines 1/22/2013 10:12:12 AM
Replikins Release: Replikin Count of Influenza H3N2 Replikin Lethality Gene in the U.S. Approaches That of 1968 H3N2 Pandemic 1/17/2013 9:29:09 AM
Replikins Release: 2012 "State Fair" Swine Flu H3N2 Outbreak in U.S. was Correctly Predicted by Increase in Genomic Replikin®Count Two Years Earlier 11/30/2012 8:37:05 AM
Five New Cases of SARS-like Virus Bring Total to Seven, Prompting Calls for Immediate Trials of New Synthetic Replikins™Vaccine SARS2012 11/28/2012 8:25:35 AM